third-news.com
Menarini Group and NewAmsterdam Pharma Gain EU Approval for Ubeslo and Evlarco
Menarini Group and NewAmsterdam Pharma have received European Commission approval for Ubeslo and Evlarco, marking a significant step in cardiovascular treatment options.